IL99864A - Compositions for suppressing transplant rejection in mammals which contain tissue donor derived MHC antigens - Google Patents

Compositions for suppressing transplant rejection in mammals which contain tissue donor derived MHC antigens

Info

Publication number
IL99864A
IL99864A IL9986491A IL9986491A IL99864A IL 99864 A IL99864 A IL 99864A IL 9986491 A IL9986491 A IL 9986491A IL 9986491 A IL9986491 A IL 9986491A IL 99864 A IL99864 A IL 99864A
Authority
IL
Israel
Prior art keywords
mammals
compositions
transplant rejection
mhc antigens
donor derived
Prior art date
Application number
IL9986491A
Other languages
English (en)
Other versions
IL99864A0 (en
Original Assignee
Autoimmune Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Autoimmune Inc filed Critical Autoimmune Inc
Publication of IL99864A0 publication Critical patent/IL99864A0/xx
Publication of IL99864A publication Critical patent/IL99864A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/001—Preparations to induce tolerance to non-self, e.g. prior to transplantation
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Zoology (AREA)
  • Transplantation (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Organic Chemistry (AREA)
  • Surgery (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
IL9986491A 1990-10-31 1991-10-27 Compositions for suppressing transplant rejection in mammals which contain tissue donor derived MHC antigens IL99864A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US60782690A 1990-10-31 1990-10-31

Publications (2)

Publication Number Publication Date
IL99864A0 IL99864A0 (en) 1992-08-18
IL99864A true IL99864A (en) 2000-11-21

Family

ID=24433875

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9986491A IL99864A (en) 1990-10-31 1991-10-27 Compositions for suppressing transplant rejection in mammals which contain tissue donor derived MHC antigens

Country Status (11)

Country Link
US (2) US5681556A (xx)
EP (1) EP0555413A4 (xx)
JP (1) JP2547162B2 (xx)
KR (1) KR0161235B1 (xx)
AU (1) AU662500B2 (xx)
BR (1) BR9107055A (xx)
CA (1) CA2093513C (xx)
HU (1) HUT63957A (xx)
IL (1) IL99864A (xx)
NO (1) NO931536L (xx)
WO (1) WO1992007581A1 (xx)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5571500A (en) * 1987-06-24 1996-11-05 Autoimmune, Inc. Treatment of autoimmune diseases through administration by inhalation of autoantigens
US5641474A (en) * 1987-06-24 1997-06-24 Autoimmune, Inc. Prevention of autoimmune diseases by aerosol administration of autoantigens
US5645820A (en) * 1987-06-24 1997-07-08 Autoimmune, Inc. Treatment of autoimmune diseases by aerosol administration of autoantigens
US5571499A (en) * 1987-06-24 1996-11-05 Autoimmune, Inc. Treatment of autoimmune diseases by aerosol administration of autoantigens
IL99699A (en) 1990-10-10 2002-04-21 Autoimmune Inc Drug with the option of oral, intra-intestinal, or inhaled dosing for suppression of autoimmune response associated with type I diabetes
MX9203138A (es) * 1991-03-12 1992-09-01 Biogen Inc Dominio de enlace cd2-de antigeno 3 (lfa-3) asociado con funcion linfositos.
WO1992016622A1 (en) * 1991-03-12 1992-10-01 Biogen, Inc. Cd2-binding domain of lymphocyte function associated antigen 3
US6764681B2 (en) 1991-10-07 2004-07-20 Biogen, Inc. Method of prophylaxis or treatment of antigen presenting cell driven skin conditions using inhibitors of the CD2/LFA-3 interaction
GB9319429D0 (en) 1993-09-21 1993-11-03 London Health Ass Methods and products for controlling immune responses in mammals
WO1995020661A1 (en) * 1994-01-27 1995-08-03 Bresatec Ltd. Materials and methods for management of hyperacute rejection in human xenotransplantation
US5849991A (en) 1994-01-27 1998-12-15 Bresatch Limited Mice homozygous for an inactivated α 1,3-galactosyl transferase gene
JPH08239324A (ja) * 1995-03-03 1996-09-17 Fusanori Hamashima 免疫抑制剤
US20020155117A1 (en) * 1996-04-04 2002-10-24 Nicole Suciu-Foca Method for detecting organ allograft rejection and uses thereof
WO1998037917A1 (en) * 1997-02-28 1998-09-03 Enzo Therapeutics, Inc., A Fully Owned Subsidiary Of Enzo Biochem, Inc. Novel processes implementing selective immune down regulation (sidr)
US7097845B2 (en) 1997-04-23 2006-08-29 Jacob Sten Petersen Combinations of antigen and mucosal binding component for inducing specific immunological tolerance
US6685936B2 (en) * 1999-10-12 2004-02-03 Osiris Therapeutics, Inc. Suppressor cells induced by culture with mesenchymal stem cells for treatment of immune responses in transplantation
US20020012667A1 (en) * 2000-05-16 2002-01-31 Mcmichael John Method for preventing allograft rejection
JP4986361B2 (ja) 2000-05-24 2012-07-25 ザ ユナイテッド ステイツ オブ アメリカ アズ リプレゼンティッド バイ ザ シークレタリー デパートメント オブ ヘルス アンド ヒューマン サービシーズ Ｅ−セレクチンに対する寛容誘導による脳卒中防止法
US20030170258A1 (en) * 2001-05-09 2003-09-11 Enzo Therapeutics, Inc. Novel processes implementing selective immune down regulation (SIDR)
AU2002320352A1 (en) 2001-07-24 2003-02-17 Biogen Idec Ma Inc. Methods for treating or preventing sclerotic disorders using cd2-binding agents
CN100512809C (zh) * 2001-10-25 2009-07-15 阿特罗吉尼克斯公司 化合物在制备用于慢性移植排斥的药物中的用途
EP1750747A1 (en) 2004-05-07 2007-02-14 Astellas US LLC Soluble lfa-3 polypeptide for treating viral disorders

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5899419A (ja) * 1981-12-07 1983-06-13 Green Cross Corp:The 免疫抑制剤
EP0105749A3 (en) * 1982-10-01 1985-05-22 BIO-COM Inc. Compositions for use in inducing immunosuppression or immunoregulation of the immune response to an antigen
US4635627A (en) * 1984-09-13 1987-01-13 Riker Laboratories, Inc. Apparatus and method
US5130297A (en) * 1988-06-23 1992-07-14 Anergen, Inc. Conjugates useful in ameliorating autoimmunity MHC-II-peptide
US5011037A (en) * 1989-11-30 1991-04-30 Adolph Coors Company Container end member
RU2054180C1 (ru) * 1991-08-21 1996-02-10 Жирнов Олег Петрович (н/п) Способ лечения вирусных респираторных инфекций

Also Published As

Publication number Publication date
AU8942691A (en) 1992-05-26
KR930701969A (ko) 1993-09-08
US5681556A (en) 1997-10-28
CA2093513A1 (en) 1992-05-01
EP0555413A4 (en) 1994-12-07
IL99864A0 (en) 1992-08-18
NO931536D0 (no) 1993-04-27
JPH05508663A (ja) 1993-12-02
WO1992007581A1 (en) 1992-05-14
BR9107055A (pt) 1993-09-21
KR0161235B1 (ko) 1998-12-01
CA2093513C (en) 1999-03-23
JP2547162B2 (ja) 1996-10-23
US5788968A (en) 1998-08-04
AU662500B2 (en) 1995-09-07
HU9301252D0 (en) 1993-07-28
NO931536L (no) 1993-04-27
HUT63957A (en) 1993-11-29
EP0555413A1 (en) 1993-08-18

Similar Documents

Publication Publication Date Title
IL99864A (en) Compositions for suppressing transplant rejection in mammals which contain tissue donor derived MHC antigens
GB8431896D0 (en) Silicone release compositions
EP0466552A3 (en) Biomedical adhesive compositions
ZA913751B (en) Controlled release composition
EP0451946A3 (en) Storage stable one-part organosiloxane compositions
BR9306345A (pt) Métodos para suprimir a habilidade de células-t de um mamífero de proliferar e para suprimir resposta imune composições para uso na supressão da capacidade de células-t de proliferarem e na supressão de resposta imune
EP0322848A3 (en) Thermally stable organosiloxane compositions and method for preparing same
EP0459675A3 (en) Adhesive organopolysiloxane composition
EP0577335A3 (en) Storage stable one-part organosiloxane compositions and methods for preparing same
GB9001694D0 (en) Immunogenic compositions
EP0453286A3 (en) Superabsorbent foam composition
GB9012397D0 (en) Mold release compositions
EP0451903A3 (en) Composition for the regulation of hair growth
EP0449613A3 (en) Graft copolymers for use as the main components of coating compositions
CA2120731A1 (en) Methods of improving allograft or xenograft tolerance by administration of an lfa-3 or cd2 binding protein
GB2255909B (en) Vaccine compositions for fish
GR1002175B (en) Method for preparing solid compositions
GB9018839D0 (en) Slow release compositions
GB8431897D0 (en) Silicone release compositions
EP0516855A4 (en) Polyisocyanate composition
AU176P (en) HAPPY DAYS Rosa hybrid
AU7481391A (en) Engrafting allogeneic tissues or organs using interleukin
IE902010L (en) Inhibiting transplant rejection
ZA916063B (en) Composition for eye drops
GB9000534D0 (en) Mould release compositions

Legal Events

Date Code Title Description
FF Patent granted
MM9K Patent not in force due to non-payment of renewal fees